Literature DB >> 31168361

What Are the Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma?

Neil Mehta1, Francis Y Yao1.   

Abstract

Entities:  

Year:  2019        PMID： 31168361      PMCID： PMC6465780          DOI： 10.1002/cld.793

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  15 in total

1.  The Impact of Median Model for End-Stage Liver Disease at Transplant Minus 3 National Policy on Waitlist Outcomes in Patients With and Without Hepatocellular Carcinoma.

Authors:  Sarah Bernards; Ryutaro Hirose; Francis Y Yao; Chengshi Jin; Jennifer L Dodge; Chiung-Yu Huang; Neil Mehta
Journal:  Liver Transpl       Date:  2021-12-08       Impact factor: 5.799

2.  Liver Transplantation in Malignancies: A Comprehensive and Systematic Review on Oncological Outcome.

Authors:  Emina Talakić; Elmar Janek; Saulius Mikalauskas; Peter Schemmer
Journal:  Visc Med       Date:  2021-07-29

3.  Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients.

Authors:  Jin Hean Koh; Darren Jun Hao Tan; Yuki Ong; Wen Hui Lim; Cheng Han Ng; Phoebe Wen Lin Tay; Jie Ning Yong; Mark D Muthiah; Eunice X Tan; Ning Qi Pang; Beom Kyung Kim; Nicholas Syn; Alfred Kow; Brian K P Goh; Daniel Q Huang
Journal:  Hepatobiliary Surg Nutr       Date:  2022-02       Impact factor: 8.265

4.  Lower Alpha-Fetoprotein Threshold of 500 ng/mL for Liver Transplantation May Improve Posttransplant Outcomes in Patients With Hepatocellular Carcinoma.

Authors:  Max L Goldman; Kali Zhou; Jennifer L Dodge; Francis Yao; Neil Mehta
Journal:  Liver Transpl       Date:  2022-01-13       Impact factor: 6.112

5.  A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.

Authors:  Neil Mehta; Jennifer L Dodge; John P Roberts; Francis Y Yao
Journal:  J Hepatol       Date:  2020-11-11       Impact factor: 25.083

6.  Living Donor Liver Transplantation for Hepatocellular Carcinoma: Appraisal of the United Network for Organ Sharing Modified TNM Staging.

Authors:  Abu Bakar Hafeez Bhatti; Anum Waheed; Nasir Ayub Khan
Journal:  Front Surg       Date:  2021-01-21

7.  Hepatocellular carcinoma progression during bridging before liver transplantation.

Authors:  P Renner; T Da Silva; A A Schnitzbauer; N Verloh; H J Schlitt; E K Geissler
Journal:  BJS Open       Date:  2021-03-05

8.  The Impact of Liver Transplantation on Hepatocellular Carcinoma Mortality in the United States.

Authors:  Parag Mahale; Meredith S Shiels; Charles F Lynch; Srinath Chinnakotla; Linda L Wong; Brenda Y Hernandez; Karen S Pawlish; Jie Li; Georgetta Alverson; Maria J Schymura; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-11-16       Impact factor: 4.090

Review 9.  Hepatocellular Carcinoma-How to Determine Therapeutic Options.

Authors:  Neil Mehta
Journal:  Hepatol Commun       Date:  2020-01-22

10.  Are the criteria always right? Assessment of hepatocellular carcinoma cases in living zzm321990donor liver transplantation at a high-volume center

Authors:  Yücel Yankol; Gültekin Hoş; Turan Kanmaz; Nesimi Mecit; Yilmaz Çakaloğlu; Münci Kalayoğlu; Koray S Acarli
Journal:  Turk J Med Sci       Date:  2021-10-21       Impact factor: 0.973
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.